Vimarsana
Biggest News Aggregation in the World

Aortech International News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aortech International. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aortech International Today - Breaking & Trending Today

TRADING UPDATES: Listing costs hobble Orcadian and ProCook earnings - Vimarsana News

TRADING UPDATES: Listing costs hobble Orcadian and ProCook earnings

TRADING UPDATES: Listing costs hobble Orcadian and ProCook earnings | Financial News

Source: lse.co.uk
TRADING UPDATES: Braemar Shipping, Egdon post improved annual results - Vimarsana News

TRADING UPDATES: Braemar Shipping, Egdon post improved annual results

TRADING UPDATES: Braemar Shipping, Egdon post improved annual results | Financial News

Source: lse.co.uk
Worldwide Bioprosthetics Industry to 2026 - Compatibility Issues With Synthetic or Mechanical Implants Presents Opportunities - Vimarsana News

Worldwide Bioprosthetics Industry to 2026 - Compatibility Issues With Synthetic or Mechanical Implants Presents Opportunities

/PRNewswire/ -- The "Bioprosthetics Market Research Report by Type, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report...

Rua Life Sciences changes chemistry in boardroom - Vimarsana News

Rua Life Sciences changes chemistry in boardroom

A Scottish chemist has joined the board of Rua Life Sciences. Caroline Stretton has been with the Aim-listed medical devices developer as its chief operating officer since Aortech International

Investegate |RUA Life Sciences Announcements | RUA Life Sciences: Half-year Report - Vimarsana News

Investegate |RUA Life Sciences Announcements | RUA Life Sciences: Half-year Report

Unaudited Interim Results RUA Life Sciences plc (AIM: RUA), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, a long-term implantable biostable polymer , announces its unaudited interim results for the six months ended 30 September 2020. Highlights · Products on schedule for regulatory submission in 2021 · Positive testing on polymeric heart valve · The Group's cash continues to be well managed with cash at 30 September 2020 of £1,009,000 (31 ...